Opinion: In Defense of Preprints
Opinion: In Defense of Preprints
In response to two November 2021 articles in The Scientist that called out preprints as a source of medical misinformation, the cofounders of bioRxiv and medRxiv say it’s not the publishing model that’s at fault.
In response to two November 2021 articles in The Scientist that called out preprints as a source of medical misinformation, the cofounders of bioRxiv and medRxiv say it’s not the publishing model that’s at fault.
biorxiv
Doctors Consider Convalescent T Cell Therapy for COVID-19
Abby Olena, PhD | Nov 6, 2020 | 3 min read
Researchers propose that an infusion of memory T cells from people who have recovered from SARS-CoV-2 infections could treat severe disease.
Gender Gap in Research Output Widens During Pandemic
Katarina Zimmer | Jun 25, 2020 | 8 min read
Experts identify childcare, which tends to fall to women, as one likely cause for the relative decrease in women’s scientific productivity compared with men’s.
Image of the Day: Handheld Science
Chia-Yi Hou | Jun 18, 2019 | 1 min read
Researchers create a 3-D printed, portable centrifuge that can be affordably produced for science classrooms.
Q&A: New Preprint Server for Clinical Research
Chia-Yi Hou | Jun 5, 2019 | 4 min read
The cofounder of bioRxiv, Richard Sever, discusses why there’s a need for the preprint server medRxiv that launched today.
All PLOS Submissions to Appear on bioRxiv
Kerry Grens | Feb 8, 2018 | 1 min read
Papers sent to PLOS journals will be automatically uploaded to the preprint server before acceptance.